Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Bio-Techne (TECH) over the last 17 years, with Q4 2025 value amounting to -$49.0 million.

  • Bio-Techne's Cash from Financing Activities rose 4157.0% to -$49.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$251.7 million, marking a year-over-year decrease of 2105.05%. This contributed to the annual value of -$253.9 million for FY2025, which is 10744.21% down from last year.
  • Per Bio-Techne's latest filing, its Cash from Financing Activities stood at -$49.0 million for Q4 2025, which was up 4157.0% from -$44.2 million recorded in Q3 2025.
  • In the past 5 years, Bio-Techne's Cash from Financing Activities registered a high of $150.8 million during Q1 2023, and its lowest value of -$90.5 million during Q2 2025.
  • For the 5-year period, Bio-Techne's Cash from Financing Activities averaged around -$31.4 million, with its median value being -$52.9 million (2021).
  • As far as peak fluctuations go, Bio-Techne's Cash from Financing Activities surged by 36316.64% in 2021, and later crashed by 28202.4% in 2025.
  • Over the past 5 years, Bio-Techne's Cash from Financing Activities (Quarter) stood at -$53.4 million in 2021, then plummeted by 35.26% to -$72.2 million in 2022, then dropped by 12.75% to -$81.4 million in 2023, then dropped by 3.0% to -$83.8 million in 2024, then soared by 41.57% to -$49.0 million in 2025.
  • Its last three reported values are -$49.0 million in Q4 2025, -$44.2 million for Q3 2025, and -$90.5 million during Q2 2025.